Tricida chapter 11 liquidation
We are advising noteholders in connection with Tricida’s chapter 11 proceedings
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
iQIYI $442 million follow-on offering
We advised the issuer on a follow-on offering of ADSs
Oesterreichische Kontrollbank $1 billion notes offering
The 4.125% notes are due 2026
Sun Pharmaceutical acquisition of Concert Pharmaceuticals
We advised Sun Pharmaceutical on the transaction
Toronto-Dominion Bank $100 million notes offering
The investment-grade notes are due 2028
New Horizon Health HK$781.7 million top-up placement of shares
We advised New Horizon Health on the top-up placement
Jinxin Fertility Group HK$1.17 billion top-up placement of shares
The shares are listed on the Hong Kong Stock Exchange
CaixaBank $1.25 billion notes offering under $5 billion U.S. MTN program
The senior non-preferred callable fixed-to-floating-rate notes are due 2029
Expro $151.8 million secondary offering
The shares are listed on the NYSE
Instant Brands drop-down structured financing transactions
We advised the borrower in connection with the transactions